ACHC Q1 2026 Earnings Call Summary | Stock Taper
Logo
ACHC

ACHC — Acadia Healthcare Company, Inc.

NASDAQ


Q1 2026 Earnings Call Summary

April 30, 2026

Acadia Healthcare (ACHC) Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

  • Revenue: $828.8 million, a 7.6% increase year-over-year.
  • Same-Facility Revenue: Grew 7.3%, driven by a 5.6% increase in revenue per patient day and a 1.6% increase in patient days.
  • Adjusted EBITDA: $144.2 million, up 7.5% year-over-year, exceeding guidance by $7.2 million.
  • Free Cash Flow: Negative $15 million, improved by $148 million compared to Q1 2025.
  • Net Leverage Ratio: Approximately 3.9x adjusted EBITDA.
  • Patient Volumes: Inpatient volumes increased by 6.2%, with acute inpatient psychiatric facilities growing revenue by 14%.

2. Strategic Updates and Business Highlights

  • Operational Focus: Emphasis on operational execution and leadership changes to improve facility performance and accountability.
  • Facility Expansion: Added 82 beds in Q1, with plans to add 400-600 beds throughout 2026, including new joint venture facilities.
  • Referral Relationships: Strengthened partnerships with referral sources, particularly in New Jersey and Maryland, to mitigate challenges in Pennsylvania.
  • Technology Investments: Continued investment in technology and data tools to enhance operational efficiency and improve care delivery.
  • Staff Retention: Improved retention rates for the eighth consecutive quarter, contributing to operational stability.

3. Forward Guidance and Outlook

  • Q2 2026 Guidance: Expected revenue between $835 million and $850 million, adjusted EBITDA of $142 million to $152 million, and adjusted EPS of $0.30 to $0.40.
  • Full-Year Guidance: Revenue guidance remains unchanged at $3.37 billion to $3.45 billion. Adjusted EBITDA guidance increased from $575-$610 million to $580-$615 million, and adjusted EPS increased from $1.30-$1.55 to $1.35-$1.60.
  • Supplemental Payments: Anticipated higher supplemental payments in the second half of 2026, contributing to improved EBITDA.

4. Bad News, Challenges, or Points of Concern

  • Specialty Facility Revenue Decline: Revenue from specialty facilities decreased by 6.5% due to challenges in Pennsylvania and closures of facilities in 2025.
  • Payer Denials and Bad Debt: Increased levels of bad debts and denials impacted financial expectations, with ongoing efforts to improve revenue cycle management.
  • Start-Up Losses: Continued losses from start-up facilities, projected to peak in Q2 before improving in the back half of the year.

5. Notable Q&A Insights

  • Correction Plans for Underperforming Facilities: Specific action plans are in place to enhance occupancy, access, and service offerings tailored to each facility's needs.
  • Payer Behavior: Bad debts and denials have worsened slightly, prompting a focus on improving documentation and compliance to enhance collections.
  • Referral Network Enhancements: Ongoing efforts to strengthen referral relationships and improve communication with partners to drive patient admissions.
  • Operational Structure Changes: Streamlining management layers to improve decision-making and operational efficiency, with a focus on aligning support with facility needs.

Overall, Acadia Healthcare reported a solid start to 2026, with strong revenue growth and operational improvements, although challenges remain in specialty facility performance and payer dynamics. The company is focused on executing its strategic initiatives to enhance care delivery and drive financial performance.